Experiences with
Glatiramer14 public posts
Want to take advantage of all our features? Just log in!
or
PPMS...
Standard FDA-approved medications for MS (for example interferons, glatiramer acetate, fingolimod) have not been proven useful in slowing the progression of PPMS. Ocrelizumab is the first FDA-approved medicine for primary progressive MS. It appears to slow the progression of disability.
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights & Diagnostic . .
Front Cell Neurosci. 2019; 13: 107.
Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
Glatopa: FDA Approves Three-Times Weekly Dose
Here is an excerpt from MSAA's article on this latest MS treatment news:
"On February 13, 2018, Sandoz, a Novartis division, announced that the United States Food and Drug Administration (FDA) approved Glatopa® (glatiramer acetate injection) at a three-times weekly 40-mg dose.